Sat-26-03-2016, 03:19 AM
(Sat-26-03-2016, 02:38 AM)jiml Wrote:Ya, I know about the article and how amgen wants to spin it. I'm just sayin' I ain't buying it. Not for a second. Amgen never stopped commercialization in japan. None of it makes sense. And why would the shareholders at valeant be so quick to pick up a dud? It works for amgen in japan but nowhere else. What works for Valeant doesn't for amgen? I'm sure there's plenty of investors that hold both stocks. Smells like big stinky hedge fund to me. Am I the only one who sees this??? I feel like I'm taking crazy pills!! Lol(Sat-26-03-2016, 02:01 AM)birdman Wrote:(Sat-06-02-2016, 23:39 PM)jiml Wrote:(Sat-06-02-2016, 23:34 PM)Quest4Cure Wrote: I read it may be approved by the FDA in the US by Nov. 2016.
So I guess they will go ahead but with a safety warning stating it can cause depression and suicidal thoughts
Not so fast quest4cure. What makes you think that brodalumab causes depression etc. What if, at the end of the day it gets fda approval with no such warning. Afterall, let's remember that amgen was merely speculating the fda would require such a warning.
I think the following quote will answer that question Amgen dump brodalumab after some patients had suicidal thoughts.